US Stock MarketDetailed Quotes
BMRA Biomerica
- 0.322
- +0.020+6.44%
Close Nov 27 16:00 ET
- 0.455
- +0.133+41.14%
Post 20:01 ET
5.42MMarket Cap-870P/E (TTM)
0.340High0.303Low10.85MVolume0.303Open0.303Pre Close5.60MTurnover69.50%Turnover RatioLossP/E (Static)16.82MShares2.13052wk High1.01P/B5.03MFloat Cap0.24252wk Low--Dividend TTM15.61MShs Float23.390Historical High--Div YieldTTM12.36%Amplitude0.170Historical Low0.516Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Biomerica Stock Forum
Mobix Labs Acquires Spacecraft Components in $18M-$24M Deal
Benzinga· Nov
📊⚡️📊
👀
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Biomerica (NASDAQ: BMRA) has secured three key patent allowances in European markets for its inFoods® Technology, targeting GERD, Crohn's Disease, and Ulcerative Colitis. The patents cover major European markets including Germany, UK, France, Italy, Spain, and over 30 other EPO nations. These markets represent significant opportunities: GERD ...
just
Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
No comment yet